Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
Swendeman D, Rotheram-Borus MJ, Arnold EM, Fernández MI, Comulada WS, Lee SJ, Ocasio MA, Ishimoto K, Gertsch W, Duan N, Reback CJ, Murphy DA, Lewis KA; Adolescent HIV Medicine Trials Network (ATN) CARES Study Team. Swendeman D, et al. Among authors: ishimoto k. Lancet Digit Health. 2024 Mar;6(3):e187-e200. doi: 10.1016/S2589-7500(23)00252-2. Lancet Digit Health. 2024. PMID: 38395539 Free article. Clinical Trial.
Post-embryonic function of GLOBULAR EMBRYO 4 (GLE4)/OsMPK6 in rice development.
Ishimoto K, Nosaka-Takahashi M, Kishi-Kaboshi M, Watanabe T, Abe K, Shimizu-Sato S, Takahashi H, Nakazono M, Hirochika H, Sato Y. Ishimoto K, et al. Plant Biotechnol (Tokyo). 2023 Mar 25;40(1):9-13. doi: 10.5511/plantbiotechnology.22.1117a. Plant Biotechnol (Tokyo). 2023. PMID: 38213919 Free PMC article.
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study.
Akahata W, Sekida T, Nogimori T, Ode H, Tamura T, Kono K, Kazami Y, Washizaki A, Masuta Y, Suzuki R, Matsuda K, Komori M, Morey AL, Ishimoto K, Nakata M, Hasunuma T, Fukuhara T, Iwatani Y, Yamamoto T, Smith JF, Sato N. Akahata W, et al. Among authors: ishimoto k. Cell Rep Med. 2023 Aug 15;4(8):101134. doi: 10.1016/j.xcrm.2023.101134. Cell Rep Med. 2023. PMID: 37586325 Free PMC article. Clinical Trial.
Tunable three-dimensional architecture of nematic disclination lines.
Modin A, Ash B, Ishimoto K, Leheny RL, Serra F, Aharoni H. Modin A, et al. Among authors: ishimoto k. Proc Natl Acad Sci U S A. 2023 Jul 4;120(27):e2300833120. doi: 10.1073/pnas.2300833120. Epub 2023 Jun 26. Proc Natl Acad Sci U S A. 2023. PMID: 37364119 Free PMC article.
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern.
Komori M, Nogimori T, Morey AL, Sekida T, Ishimoto K, Hassett MR, Masuta Y, Ode H, Tamura T, Suzuki R, Alexander J, Kido Y, Matsuda K, Fukuhara T, Iwatani Y, Yamamoto T, Smith JF, Akahata W. Komori M, et al. Among authors: ishimoto k. Nat Commun. 2023 May 19;14(1):2810. doi: 10.1038/s41467-023-38457-x. Nat Commun. 2023. PMID: 37208330 Free PMC article.
Squirmer hydrodynamics near a periodic surface topography.
Ishimoto K, Gaffney EA, Smith DJ. Ishimoto K, et al. Front Cell Dev Biol. 2023 Apr 13;11:1123446. doi: 10.3389/fcell.2023.1123446. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37123410 Free PMC article.
Most probable path of an active Brownian particle.
Yasuda K, Ishimoto K. Yasuda K, et al. Among authors: ishimoto k. Phys Rev E. 2022 Dec;106(6-1):064120. doi: 10.1103/PhysRevE.106.064120. Phys Rev E. 2022. PMID: 36671105
241 results